Cepheid
- Raised $5.2 million (2013)
- 10 clinical trials, 1 active
- FDA-cleared or approved devices
- Research grants: $8.3 million
Life science companies
Explore 12,266 biotech, pharmaceutical, medical device, CRO and CDMO companies. Filter by type, location, clinical trials, funding, FDA registrations and research focus, then see the insights or the map. Free, and new companies are added every day.
Amgen Inc
Nasdaq: AMGN
- Private funding (2015)
- 1118 clinical trials, 106 active
- 4 FDA-registered drug sites
- Research grants: $600,000
Delcath Systems, Inc.
Nasdaq: DCTH
- Raised $7 million (2024)
- 11 clinical trials, 3 active
- 2 FDA-registered device sites
- 1 FDA-registered drug site
Design Therapeutics, Inc.
Nasdaq: DSGN
- Raised $125 million (2021)
- 5 clinical trials, 3 active
- Research grants: $1.1 million
- Founded 2017
Biotricity Inc.
OTC: BTCY
- Raised $1 million (2024)
- FDA-cleared or approved devices
- Research grants: $480,106
- Founded 2012
Twist Bioscience
Nasdaq: TWSTOn BioBridgeX
- Raised $50 million (2018)
- 1 FDA-registered device site
- Founded 2013
Spark Biomedical Inc.
- Raised $16 million (2023)
- 16 clinical trials, 6 active
- FDA-cleared or approved devices
- Research grants: $12 million
Aprea Therapeutics, Inc.
Nasdaq: APRE
- Raised $3.1 million (2025)
- 12 clinical trials, 1 active
- Research grants: $4 million
Arvinas, Inc.
Nasdaq: ARVN
- Raised $32 million (2019)
- 5 clinical trials, 3 active
- Research grants: $2.1 million
- Founded 2013
Soleno Therapeutics Inc
- Raised $60 million (2023)
- 7 clinical trials, 2 active
- Research grants: $4.4 million
Soligenix, Inc.
Nasdaq: SNGX
- Raised $2 million (2017)
- 11 clinical trials
- Research grants: $12 million
Liquidia Corp
Nasdaq: LQDA
- Raised $22 million (2021)
- 10 clinical trials, 6 active
- 1 FDA-registered drug site
- Research grants: $140,760
Abbott Laboratories
NYSE: ABT
- Raised $100,000 (2011)
- 387 clinical trials, 4 active
- FDA-cleared or approved devices
Schrodinger
Nasdaq: SDGROn BioBridgeX
- Raised $108 million (2019)
- 3 clinical trials, 2 active
Lipella Pharmaceuticals Inc.
OTC: LIPO
- Raised $9,000 (2025)
- 3 clinical trials
- Research grants: $14 million
- Founded 2005
Intra-Cellular Therapies, Inc.
- Raised $60 million (2013)
- 41 clinical trials, 11 active
- Research grants: $4.2 million
- Founded 2012
BioCardia, Inc.
Nasdaq: BCDA
- Raised $4 million (2019)
- 6 clinical trials, 3 active
- FDA-cleared or approved devices
- Research grants: $236,593
SI-BONE, Inc.
Nasdaq: SIBN
- Raised $11 million (2010)
- 13 clinical trials, 5 active
- FDA-cleared or approved devices
- Founded 2008
Context Therapeutics Inc.
Nasdaq: CNTX
- Raised $100 million (2024)
- 5 clinical trials, 3 active
- Research grants: $450,444
- Founded 2021
Mustang Bio, Inc.
Nasdaq: MBIO
- Raised $2.5 million (2024)
- 3 clinical trials
- Research grants: $4 million
- Founded 2015
Navidea Biopharmaceuticals, Inc.
- Raised $14 million (2010)
- 19 clinical trials
- Research grants: $19 million
Sonavex, Inc.
- Raised $15 million (2024)
- 4 clinical trials, 1 active
- FDA-cleared or approved devices
- Research grants: $15 million
REGENXBIO Inc.
Nasdaq: RGNX
- Raised $71 million (2015)
- 24 clinical trials, 13 active
- 1 FDA-registered drug site
- Research grants: $1 million
Thermo Fisher Scientific Inc.
NYSE: TMO
- Raised $500 million (2014)
- 6 clinical trials, 1 active
- FDA-cleared or approved devices
Alector, Inc.
Nasdaq: ALEC
- Raised $32 million (2015)
- 12 clinical trials, 1 active
- Research grants: $2.8 million
- Founded 2013
Aethlon Medical Inc
Nasdaq: AEMD
- Raised $2.2 million (2025)
- 3 clinical trials
- Research grants: $2.8 million
NVN Liquidation, Inc.
- Raised $33 million (2015)
- 21 clinical trials
- Research grants: $7.9 million
- Founded 2006
Inmune Bio, Inc.
Nasdaq: INMB
- Raised $4.7 million (2019)
- 7 clinical trials
- Research grants: $3.9 million
- Founded 2015
Biolinq Inc
- Raised $90 million (2025)
- 2 clinical trials
- FDA-cleared or approved devices
- Research grants: $9.5 million
Azitra, Inc.
NYSE: AZTR
- Raised $4.3 million (2022)
- 4 clinical trials, 1 active
- Research grants: $750,000
- Founded 2014
Scynexis Inc
Nasdaq: SCYX
- Raised $11 million (2012)
- 18 clinical trials
- 1 FDA-registered drug site
- Research grants: $448,280
Encore Medical, Inc.
- Raised $1.1 million (2022)
- 22 clinical trials, 2 active
- FDA-cleared or approved devices
- Founded 2017
Eyenuk, Inc.
- Raised $5.6 million (2026)
- 4 clinical trials
- FDA-cleared or approved devices
- Research grants: $20 million
Zenflow, Inc.
- Raised $19 million (2024)
- 7 clinical trials, 2 active
- FDA-cleared or approved devices
- Research grants: $5.1 million
Click Therapeutics, Inc.
- Raised $49 million (2025)
- 17 clinical trials
- FDA-cleared or approved devices
- Research grants: $899,766
Brainsway Ltd.
Nasdaq: BWAY
- Raised $20 million (2024)
- 21 clinical trials, 1 active
- FDA-cleared or approved devices
Lumicell, Inc.
- Raised $198 million (2025)
- 11 clinical trials, 3 active
- FDA-cleared or approved devices
- Research grants: $5.6 million
MAIA Biotechnology, Inc.
NYSE: MAIA
- Raised $1.5 million (2026)
- 2 clinical trials, 2 active
- Research grants: $2.3 million
Transcode Therapeutics, Inc.
Nasdaq: RNAZ
- Raised $8 million (2024)
- 2 clinical trials, 1 active
- Research grants: $8.6 million
Hologic Inc
- Raised $450 million (2010)
- 28 clinical trials, 2 active
- FDA-cleared or approved devices
Shape Memory Medical Inc.
- Raised $17 million (2026)
- 8 clinical trials, 7 active
- FDA-cleared or approved devices
- Research grants: $4.8 million
Polarean, Inc.
- Raised $1.9 million (2015)
- 3 clinical trials
- FDA-cleared or approved devices
- 1 FDA-registered drug site
PROCEPT BioRobotics Corp
Nasdaq: PRCT
- Raised $85 million (2021)
- 13 clinical trials, 3 active
- FDA-cleared or approved devices
LENSAR, Inc.
Nasdaq: LNSR
- Raised $20 million (2023)
- 4 clinical trials
- FDA-cleared or approved devices
- Founded 2004
Lineage Cell Therapeutics, Inc.
NYSE: LCTX
- Raised $3.5 million (2014)
- 5 clinical trials, 3 active
- Research grants: $6.3 million
Mercator Medsystems Inc
- Raised $14 million (2019)
- 10 clinical trials, 3 active
- FDA-cleared or approved devices
- Research grants: $15 million
UroGen Pharma Ltd.
Nasdaq: URGN
- Raised $120 million (2023)
- 19 clinical trials, 4 active
- FDA-cleared or approved devices
Pfizer Inc
NYSE: PFE
- 3566 clinical trials, 249 active
- FDA-cleared or approved devices
- 7 FDA-registered drug sites
electroCore, Inc.
Nasdaq: ECOR
- Raised $1.9 million (2025)
- 20 clinical trials, 1 active
- FDA-cleared or approved devices
- Founded 2018
RefleXion Medical, Inc.
- Raised $107 million (2023)
- 3 clinical trials, 2 active
- FDA-cleared or approved devices
- Research grants: $6.4 million
Published company profiles only; counts update daily. Data licences